DK134348C - Analogifremgangsmade til fremstilling af d-homo-20-ketopregnaner - Google Patents

Analogifremgangsmade til fremstilling af d-homo-20-ketopregnaner

Info

Publication number
DK134348C
DK134348C DK604174A DK604174A DK134348C DK 134348 C DK134348 C DK 134348C DK 604174 A DK604174 A DK 604174A DK 604174 A DK604174 A DK 604174A DK 134348 C DK134348 C DK 134348C
Authority
DK
Denmark
Prior art keywords
ketopregnars
homo
making
analogical procedure
analogical
Prior art date
Application number
DK604174A
Other languages
Danish (da)
English (en)
Other versions
DK134348B (da
DK604174A (enExample
Inventor
U Kerb
R Wiechert
K Kieslich
K Petzoldt
H Wachtel
D Palenschat
R Horowski
G Paschelke
W Kehr
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE2360443A external-priority patent/DE2360443A1/de
Priority claimed from DE19742445161 external-priority patent/DE2445161A1/de
Application filed by Schering Ag filed Critical Schering Ag
Publication of DK604174A publication Critical patent/DK604174A/da
Publication of DK134348B publication Critical patent/DK134348B/da
Application granted granted Critical
Publication of DK134348C publication Critical patent/DK134348C/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J63/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by expansion of only one ring by one or two atoms
    • C07J63/008—Expansion of ring D by one atom, e.g. D homo steroids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P33/00—Preparation of steroids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Steroid Compounds (AREA)
DK604174A 1973-11-30 1974-11-20 Analogifremgangsmade til fremstilling af d-homo-20-ketopregnaner DK134348C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE2360443A DE2360443A1 (de) 1973-11-30 1973-11-30 D-homo-20-ketopregnane
DE19742445161 DE2445161A1 (de) 1974-09-19 1974-09-19 D-homo-20-ketopregnane ii

Publications (3)

Publication Number Publication Date
DK604174A DK604174A (enExample) 1975-07-28
DK134348B DK134348B (da) 1976-10-25
DK134348C true DK134348C (da) 1977-03-21

Family

ID=25766200

Family Applications (1)

Application Number Title Priority Date Filing Date
DK604174A DK134348C (da) 1973-11-30 1974-11-20 Analogifremgangsmade til fremstilling af d-homo-20-ketopregnaner

Country Status (14)

Country Link
US (1) US4045574A (enExample)
JP (1) JPS5084561A (enExample)
AT (1) AT347611B (enExample)
CA (1) CA1030522A (enExample)
CH (1) CH618183A5 (enExample)
DD (1) DD115659A5 (enExample)
DK (1) DK134348C (enExample)
ES (1) ES432106A1 (enExample)
FR (1) FR2253512B1 (enExample)
GB (1) GB1494097A (enExample)
IE (1) IE40423B1 (enExample)
IL (1) IL46153A (enExample)
NL (1) NL7415577A (enExample)
SE (1) SE408426B (enExample)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4879316A (en) * 1987-02-26 1989-11-07 The University Of Tennessee Research Corporation Interpenetrating polymer network ion exchange membranes and method for preparing same
US6787530B1 (en) 1996-08-23 2004-09-07 Monash University Use of pregnane-diones as analgesic agents
US20040034215A1 (en) * 2002-08-16 2004-02-19 White Michael J. 5-Androsten-3beta-ol steroid intermediates and processes for their preparation
US20070066579A1 (en) * 2002-08-16 2007-03-22 White Michael J 5-androsten-3beta-ol steroid intermediates and processs for their preparation
US20160068563A1 (en) 2013-04-17 2016-03-10 Boyd L. Harrison 19-nor neuroactive steroids and methods of use thereof
KR102396328B1 (ko) 2013-04-17 2022-05-10 세이지 테라퓨틱스, 인크. 19-노르 c3,3-이치환된 c21-n-피라졸릴 스테로이드 및 그의 사용 방법
EP2986624B1 (en) 2013-04-17 2020-03-25 Sage Therapeutics, Inc. 19-nor neuroactive steroids for methods of treatment
US9725481B2 (en) 2013-04-17 2017-08-08 Sage Therapeutics, Inc. 19-nor C3, 3-disubstituted C21-C-bound heteroaryl steroids and methods of use thereof
SI3021852T1 (sl) 2013-07-19 2021-07-30 Sage Therapeutics, Inc. Nevroaktivni steroidi, sestavki in uporabe le-teh
AU2014308621C1 (en) 2013-08-23 2022-01-06 Sage Therapeutics, Inc. Neuroactive steroids, compositions, and uses thereof
US10246482B2 (en) 2014-06-18 2019-04-02 Sage Therapeutics, Inc. Neuroactive steroids, compositions, and uses thereof
CN117024501A (zh) 2014-10-16 2023-11-10 萨奇治疗股份有限公司 靶向cns障碍的组合物和方法
ME03809B (me) 2014-10-16 2021-04-20 Sage Therapeutics Inc KOMPOZICIJE I POSTUPCI ZA LEČENJE POREMEĆAJA CNS-a
WO2016082789A1 (en) 2014-11-27 2016-06-02 Sage Therapeutics, Inc. Compositions and methods for treating cns disorders
RS61530B1 (sr) 2015-01-26 2021-04-29 Sage Therapeutics Inc Kompozicije i postupci za lečenje poremećaja cns
EP4155314A1 (en) 2015-02-20 2023-03-29 Sage Therapeutics, Inc. Neuroactive steroids, compositions, and uses thereof
MA45599A (fr) 2016-07-11 2019-05-15 Sage Therapeutics Inc Stéroïdes neuroactifs substitués en c17, c20 et c21 et leurs procédés d'utilisation
WO2018013615A1 (en) 2016-07-11 2018-01-18 Sage Therapeutics, Inc. C7, c12, and c16 substituted neuroactive steroids and their methods of use
BR112020012761A2 (pt) * 2017-12-22 2021-02-17 Sage Therapeutics, Inc. composições e métodos para o tratamento de distúrbios do snc
KR20250174100A (ko) 2018-12-05 2025-12-11 세이지 테라퓨틱스, 인크. 신경활성 스테로이드 및 이의 사용 방법
CN115651054B (zh) 2019-01-08 2024-06-21 成都康弘药业集团股份有限公司 甾体类化合物、用途及其制备方法
SG11202112391UA (en) 2019-05-31 2021-12-30 Sage Therapeutics Inc Neuroactive steroids and compositions thereof
JP7754725B2 (ja) * 2019-06-27 2025-10-15 セージ セラピューティクス， インコーポレイテッド Ｃｎｓ障害を治療するための組成物及び方法
CA3143509A1 (en) 2019-06-27 2020-12-30 Sage Therapeutics, Inc. Compositions and methods for treating cns disorders
CN114729000A (zh) * 2019-06-27 2022-07-08 萨奇治疗股份有限公司 用于治疗cns病症的化合物

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2860158A (en) * 1954-10-18 1958-11-11 Sterling Drug Inc Compounds of the perhydrochrysene series and preparation thereof
US3686223A (en) * 1968-12-26 1972-08-22 Sterling Drug Inc D-homoestratrienes
US3833621A (en) * 1972-03-20 1974-09-03 Richardson Merrell Inc 3-keto-7(alpha,beta)-loweralkyl-delta5 steroids and process for preparing same

Also Published As

Publication number Publication date
DK134348B (da) 1976-10-25
SE7414960L (enExample) 1975-06-02
CH618183A5 (enExample) 1980-07-15
DK604174A (enExample) 1975-07-28
CA1030522A (en) 1978-05-02
AU7586774A (en) 1976-06-03
JPS5084561A (enExample) 1975-07-08
FR2253512B1 (enExample) 1978-02-03
SE408426B (sv) 1979-06-11
FR2253512A1 (enExample) 1975-07-04
ES432106A1 (es) 1976-11-01
IE40423L (en) 1975-05-30
ATA950774A (de) 1978-05-15
IL46153A0 (en) 1975-02-10
IE40423B1 (en) 1979-05-23
AT347611B (de) 1979-01-10
DD115659A5 (enExample) 1975-10-12
NL7415577A (nl) 1975-06-03
GB1494097A (en) 1977-12-07
US4045574A (en) 1977-08-30
IL46153A (en) 1979-01-31

Similar Documents

Publication Publication Date Title
DK134348C (da) Analogifremgangsmade til fremstilling af d-homo-20-ketopregnaner
DK138501C (da) Analogifremgangsmaade til fremstilling af 3alfa-hydroxy-d-homo-5alfa-pregnan-11,20-dioner
DK132892C (da) Analogifremgangsmade til fremstilling af 4-aminoquinazoliner
DK133051C (da) Analogifremgangsmade til fremstilling af 1,3-oxygenerede 8alfa-ostratriener
DK456077A (da) Fremgangsmade til fremstilling af nicotinsyre
DK132707C (da) Analogifremgangsmade til fremstilling af 1,3,16,17-tetraoxygenerede 8alfa-ostratriener
DK133104C (da) Analogifremgangsmade til fremstilling af 9-substituerede aminoimidazo(4,5-f)kinoliner
DK136729C (da) Analogifremgangsmaade til fremstilling af 1alfa,17beta-dihydroxy-17beta-alkynyl-4-oestren-3-oner
DK133050C (da) Analogifremgangsmade til fremstilling af 3,17,18-trihydroxy-1,3,5(10)-ostratriener
DK136155C (da) Analogifremgangsmade til fremstilling af pyrazoloner-(5)
DK137086B (da) Analogifremgangsmade til fremstilling af pregnan-21-syrederivater
DK135119C (da) Analogifremgangsmade til fremstilling af 3-pyrazolyloksyeddikesyrederivater
DK132328C (da) Analogifremgangsmade til fremstilling af 17beta-hydroxy-16,16-dimethylestr-4-en-3-on
DK131633C (da) Fremgangsmade til fremstilling af 3-(17beta-4-androsten-3-on-17beta-yl)-propiolacton
DK136249C (da) Analogifremgangsmade til fremstilling af xanthenderivater
DK132410C (da) Analogifremgangsmade til fremstilling af 2-amino-4h-pyraner
DK137388B (da) Analogifremgangsmade til fremstilling af et pyrazinoisoquinolinderivat
DK142578A (da) Analogifremgangsmaade til fremstilling af 4-benzazininderivater
DK133303C (da) Analogifremgangsmade til fremstilling af digitoxinorthoformiater
DK135580C (da) Fremgangsmade til fremstilling af bis-halogencarbonylaniliner
DK153154C (da) Fremgangsmaade til fremstilling af 7-acylamido-cephalosporin-forbindelser
DK132439C (da) Analogifremgangsmade til fremstilling af 17-steroidylestratriener
DK134399C (da) Analogifremgangsmade til fremstilling af benzoylphenylisothiourinstoffer
DK200477A (da) Analogifremgangsmade til fremstilling af isoxazolderivater
DK132432C (da) Analogifremgangsmade til fremstilling af 2-amino-2-imidazolinderivater